|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total Current Assets | |||||||
| Marketable securities held in Trust Account | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||
| Current liabilities | |||||||
| Accrued expenses | |||||||
| Accrued offering costs | |||||||
| Due to Sponsor | |||||||
| Income taxes payable | |||||||
| Promissory note - related party | |||||||
| Total Current Liabilities | |||||||
| Deferred underwriting payable | |||||||
| Total Liabilities | |||||||
| Class A common stock subject to possible redemption, 10,352,040 shares at redemption value of $ 10.02 and $10.00 at September 30, 2022 and December 31, 2021, respectively | |||||||
| Class A Common Stock | |||||||
| Total class A common stock subject to possible redemption, 10,352,040 shares at redemption value of $ 10.02 and $10.00 at September 30, 2022 and December 31, 2021, respectively | |||||||
| Stockholders' Deficit | |||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |||||||
| Common stock | |||||||
| Class A Common Stock | |||||||
| Class B Common Stock | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Stockholders' Deficit | |||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
Loading...